National Vaccine
Information Center

Your Health. Your Family. Your Choice.
Search Results

From the 1/14/2022 release of VAERS data:

This is VAERS ID 1067086

Government Disclaimer on use of this data

Case Details

VAERS ID: 1067086 (history)  
Form: Version 2.0  
Age: 65.0  
Sex: Female  
Location: Rhode Island  
   Days after vaccination:16
Submitted: 0000-00-00
Entered: 2021-03-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Senior Living       Purchased by: ?
Symptoms: Blood test, Fatigue, Guillain-Barre syndrome, Immunoglobulin therapy, Muscular weakness, Neurological examination, Paraesthesia
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Armour thyroid, Trazedone, QVAR inhaler, Nasonex, melatonin, multi-vitamin, turmeric, vitamin D
Current Illness: none
Preexisting Conditions: hypothyroid
Allergies: NKA
Diagnostic Lab Data: Neurological evaluation and multiple blood tests upon hospitalization 2/15.
CDC Split Type:

Write-up: Guillain-Barre Syndrome. 3-day hospitalization, IVIg infusion. Symptoms of tingling feet (started in toes and progressed to whole foot), lower leg weakness and fatigue began 16 days post vaccination. Hospitalization 4 days post symptom onset.

New Search

Link To This Search Result:

Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166